Bio Conscious Announces Strategic API Integration with Dexcom to Enhance Diabetes Care

VANCOUVER, BC and HOUSTON, TX – Bio Conscious Technologies Inc., a prominent player in AI and Health Technology, disclosed a pivotal API integration with Dexcom, a leader in real-time continuous glucose monitoring (CGM). This collaboration emphasizes secure real-time data integration from Dexcom’s CGM into Bio Conscious’ AI-powered Endobits platform, aiming to transform diabetes management in clinical settings.

The integration facilitates secure data monitoring and enhances patient care by incorporating advanced algorithmic models which offer precise health forecasting. Endobits, powered by GPT 4 large language models, strives to optimize the efficiency and quality of diabetes treatment aligned with the latest American Diabetes Association guidelines. Amir Hayeri, CEO of Bio Conscious, highlighted the integration’s capacity to provide superior results for healthcare practitioners and patients.

This API partnership will enable efficient, AI-driven analysis of patient data, thereby reducing the workload of healthcare professionals and lowering operational costs while improving patient outcomes. Healthcare centers interested in leveraging the technology offered by Endobits are encouraged to reach out via Bio Conscious' website.